Koers Takeda Pharmaceutical Company Limited Fukuoka Stock Exchange
Aandelen
4502
JP3463000004
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4.080 JPY | -1,21% | -.--% | +2,13% |
Omzet 2024 | 4.264 mld. 27,28 mld. 25,06 mld. | Omzet 2025 * | 4.252 mld. 27,2 mld. 24,99 mld. | Marktkapitalisatie | 6.594 mld. 42,18 mld. 38,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 144 mld. 922 mln. 847 mln. | Nettowinst (verlies) 2025 * | 116 mld. 745 mln. 684 mln. | EV/omzet 2024 | 1,54 x |
Nettoschuld 2024 * | 3.771 mld. 24,12 mld. 22,16 mld. | Nettoschuld 2025 * | 4.224 mld. 27,02 mld. 24,83 mld. | EV/omzet 2025 * | 2,54 x |
K/w-verhouding 2024 |
45,4
x | K/w-verhouding 2025 * |
59,8
x | Werknemers | - |
Dividendrendement 2024 |
4,49% | Dividendrendement 2025 * |
4,6% | Vrij verhandelbaar | 99,12% |
Recentste transcriptie over Takeda Pharmaceutical Company Limited
1 maand | -5,01% | ||
Lopend jaar | +2,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 01-04-14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-02-22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 01-01-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 01-06-16 | |
Ian Clark
BRD | Director/Board Member | 62 | 01-01-19 |
Steven Gillis
BRD | Director/Board Member | 71 | 01-01-19 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,69% | 749 mld. | |
+38,50% | 605 mld. | |
-6,87% | 351 mld. | |
+18,74% | 328 mld. | |
+6,76% | 292 mld. | |
+11,26% | 216 mld. | |
-2,66% | 214 mld. | |
+2,64% | 167 mld. | |
+6,72% | 165 mld. |
- Beurs
- Aandelen
- Koers 4502
- Koers 4502